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Minor spliceosome, major surprise: it’s cytoplasmic
O
ne of the great surprises of modern biology was the 
discovery of introns and the consequent understanding 
that gene transcripts are spliced to form mature messenger 
RNA (mRNA). A further surprise was the recent discovery that 
there are two kinds of splicing systems, the major and minor, 
which act on different types of introns. Now, Harald König, Ferenc 
Müller (Institute for Toxicology and Genetics, Karlsruhe, Germany), 
and colleagues uncover yet one more surprise: the minor system 
acts not in the nucleus, but in the cytoplasm.
The minor spliceosome, found primarily in plants and 
animals, edits less than 1% of all introns, which are characterized 
by unique sequences at the splice sites. All genes containing 
minor introns also contain major introns, which are processed by 
the major spliceosome in the nucleus. Despite their rarity, minor 
introns are evolutionarily conserved, suggesting they have some 
important properties. Genes with minor introns include the E2F 
transcription factors and genes of the MAP kinase pathway.
The authors used in situ hybridization in zebraﬁ  sh  and 
mammalian cells to show that snRNAs of the minor spliceosome 
are primarily cytoplasmic. mRNAs that had their major introns 
removed but still contained minor introns were transported to the 
cytoplasm. The minor spliceosome can be inhibited by an antisense 
morpholino that obstructs access to the minor introns. Attaching a 
nuclear export signal to the morpholino, so that it primarily 
localized to the cytoplasm, further inhibited the spliceosome.
The authors reason that its cytoplasmic location might 
allow the minor spliceosome to continue to function during 
mitosis, when the nucleus is in disarray. They found that 
transcripts containing major introns accumulated during mitosis 
as expected, but transcripts containing only minor introns did 
not, suggesting that minor splicing continues even while the 
nucleus is being reorganized.
Suppression of minor spliceosome activity suggested that the 
minor spliceosome might regulate cell proliferation. In zebraﬁ  sh, 
its suppression halted development during the formation of muscle 
and vertebra precursors, apparently due to increased apoptosis 
and a block in cell cycle progression. In human cells, the 
suppression prevented cells from progressing beyond G1.
So why is the minor splicing system segregated to the 
cytoplasm? “The minor system is much slower,” says Koenig. “It 
could be that its cytoplasmic localization evolved to cope with 
that slower processing, by following partially spliced transcripts 
into the cytoplasm.” Its segregation and specialization may 
explain the evolutionary conservation of the minor spliceosome 
in the face of a far more efﬁ  cient nuclear system.
Reference: König, H., et al. 2007. Cell. 131:718–729.
T
o do its job of degrading misfolded 
proteins, the proteasome’s core 
particle (CP) and regulatory parti-
cle (RP) must link up. But what keeps them 
together while they work? According to 
new research by Maurits Kleijnen, Jeroen 
Roelofs, Daniel Finley (Harvard Medical 
School, Boston, MA), and colleagues, 
having something to chew on might keep the 
proteasome intact until the job is fi  nished.
The proteasome’s active sites sit deep 
within its core, far removed from its regu-
latory particles, which cap the ends of the 
proteolytic tunnel. Nonetheless, protea-
some inhibitors that bind to the core’s 
active site, such as epoxomicin, make it 
more likely that the core and regulatory 
units coprecipitate, suggesting that inhibi-
tors may stabilize the interface between 
the two despite their distance.
To test this theory, the authors treated 
purifi   ed proteasome constituents with 
apyrase, which destabilizes and inactivates 
the proteasome by hydrolyzing its bound 
ATP and ADP cofactors to AMP. With 
apyrase alone, the two complexes separated 
readily. But if the authors also added in-
creasing concentrations of epoxomicin, the 
proportion of linked and active units in-
creased. “No one had noticed this before,” 
Finley says. “Only by following both the 
assembly state and the activity state at the 
same time can you see this effect.”
It is not yet clear whether the protein 
substrates normally degraded by the 
proteasome exert the same linking–acti-
vating effect, although Finley expects 
they will. The group is also not sure how 
a conformational change in the buried 
active site alters the binding of core and 
regulatory particles. Experiments to an-
swer both questions are in progress. But it 
would make sense that protein substrates 
prevent subunit dissociation, Finley says, 
since once degradation of a protein begins, 
its stabilizing effect on the proteasome 
will both ensure the job gets fi  nished 
and prevent harmful intermediaries from 
lingering in the cell.
Reference: Kleijnen, M.F., et al. 2007. Nat. 
Struct. Mol. Biol. doi:10.1038/nsmb1335.
In zebraﬁ  sh, snRNAs (black) of the major spliceosome accumulate in the 
nucleus (left), while those of the minor spliceosome are cytoplasmic (right).
The proteasome remains assembled (RP2-CP 
and RP1-CP) in the presence of its inhibitor. 
But as inhibitor concentration falls, the core 
particle (CP) separates.
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A chewing proteasome is stabilized